Praveen Kumar Dhandapani

Praveen Kumar Dhandapani is an accomplished Research Scientist currently working at Orion Pharma since October 2019, specializing in Antibodies and Drug Conjugates. This role followed a transition in 2022 during a company reorganization, where Praveen independently managed early-stage project ideation and evaluation. Prior experiences include work with the New Targets and Therapeutics team at Orion Pharma, where valuable training was gained in identifying druggable targets for rare neurological disorders. Praveen's academic background includes a PhD from the University of Helsinki, focusing on mitochondrial respiratory chain dysfunction in cardiomyopathy, along with research experience at Uppsala University, Stockholm University, and the Indian Council of Medical Research, involving diverse biological investigations. Educational qualifications include a Bachelor of Technology in Biotechnology from Anna University Chennai and a Master's in Applied Biotechnology from Uppsala University.